These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15316355)

  • 1. Biased G-to-A hypermutation in HIV-1 proviral DNA from a long-term non-progressor.
    Wei M; Xing H; Hong K; Huang H; Tang H; Qin G; Shao Y
    AIDS; 2004 Sep; 18(13):1863-5. PubMed ID: 15316355
    [No Abstract]   [Full Text] [Related]  

  • 2. A new type of G-->A hypermutation affecting human immunodeficiency virus.
    Fitzgibbon JE; Mazar S; Dubin DT
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):833-8. PubMed ID: 7504935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of real-time PCR methods for measurement of HIV-1 proviral DNA.
    Rozera G; Abbate I; Bruselles A; Bartolini B; D'Offizi G; Nicastri E; Tommasi C; Capobianchi MR
    J Virol Methods; 2010 Mar; 164(1-2):135-8. PubMed ID: 19963009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of HIV-1 proviral DNA relative to cellular DNA by the polymerase chain reaction.
    Kellogg DE; Sninsky JJ; Kwok S
    Anal Biochem; 1990 Sep; 189(2):202-8. PubMed ID: 2281864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of HIV-1 group M proviral DNA using TaqMan MGB real-time PCR.
    Kondo M; Sudo K; Tanaka R; Sano T; Sagara H; Iwamuro S; Takebe Y; Imai M; Kato S
    J Virol Methods; 2009 May; 157(2):141-6. PubMed ID: 19126416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research of status of provirus HIV DNA in non-progressor and progressor of HIV-1 infected persons.
    Xu X; Chen L; Wang Q; Chermann JC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):333-7. PubMed ID: 11471019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two TaqMan PCR assays for the detection of HIV-1 proviral DNA in blood samples.
    Moroney SM; Heller LC; Widen RH
    J Microbiol Methods; 2006 May; 65(2):350-3. PubMed ID: 16169104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men.
    Bagasra O; Farzadegan H; Seshamma T; Oakes JW; Saah A; Pomerantz RJ
    AIDS; 1994 Dec; 8(12):1669-74. PubMed ID: 7888115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of HIV-1 DNA in high-risk seronegative individuals using high-input polymerase chain reaction.
    Dis Markers; 1991; 9(6):351. PubMed ID: 1823325
    [No Abstract]   [Full Text] [Related]  

  • 10. Distinctive Drug-resistant Mutation Profiles and Interpretations of HIV-1 Proviral DNA Revealed by Deep Sequencing in Reverse Transcriptase.
    Yin QQ; Li ZP; Zhao H; Pan D; Wang Y; Xu WS; Xing H; Feng Y; Jiang SB; Shao YM; Ma LY
    Biomed Environ Sci; 2016 Apr; 29(4):239-47. PubMed ID: 27241734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry in situ polymerase chain reaction as an innovative approach to HIV-1 proviral DNA detection.
    Gibellini D; Zauli G; Re MC; Furlini G; La Placa M
    Eur J Histochem; 1998; 42(2):137-41. PubMed ID: 9728291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variability affects the detection of HIV by polymerase chain reaction.
    Candotti D; Jung M; Kerouedan D; Rosenheim M; Gentilini M; M'Pele P; Huraux JM; Agut H
    AIDS; 1991 Aug; 5(8):1003-7. PubMed ID: 1777158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments.
    Bruisten SM; Koppelman MH; Roos MT; Loeliger AE; Reiss P; Boucher CA; Huisman HG
    AIDS; 1993 Nov; 7 Suppl 2():S15-20. PubMed ID: 8161441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of HIV-1 proviral DNA in peripheral blood monocytes and dendritic cells from HIV-1-infected individuals.
    Hsia K; Tsai V; Zvaifler NJ; Spector SA
    AIDS; 1995 Apr; 9(4):398-9. PubMed ID: 7794548
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV-1 proviral resistance mutations: usefulness in clinical practice.
    Kabamba-Mukadi B; Duquenne A; Henrivaux P; Musuamba F; Ruelle J; Yombi JC; Bodéus M; Vandercam B; Goubau P
    HIV Med; 2010 Sep; 11(8):483-92. PubMed ID: 20163482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative recovery of proviral HIV-1 DNA from leukocytes by the Dried Buffy Coat Spot method for real-time PCR determination.
    Rossi de Gasperis M; Caione MD; Concato C; Fiscarelli E; Di Pietro N; Salotti V; Putignani L; Menichella D; Callea F
    J Virol Methods; 2010 Dec; 170(1-2):121-7. PubMed ID: 20863854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
    Gibellini D; Vitone F; Schiavone P; Ponti C; La Placa M; Re MC
    J Clin Virol; 2004 Apr; 29(4):282-9. PubMed ID: 15018857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The polymerase chain reaction in the diagnosis and prognosis of HIV infection].
    Radiuk SN; Matsevich GR; Andzhaparidze OG
    Vopr Virusol; 1994; 39(3):98-101. PubMed ID: 8091758
    [No Abstract]   [Full Text] [Related]  

  • 19. Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions.
    Yerly S; Günthard HF; Fagard C; Joos B; Perneger TV; Hirschel B; Perrin L;
    AIDS; 2004 Sep; 18(14):1951-3. PubMed ID: 15353981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse transcriptase and substrate dependence of the RNA hypermutagenesis reaction.
    Martínez MA; Sala M; Vartanian JP; Wain-Hobson S
    Nucleic Acids Res; 1995 Jul; 23(14):2573-8. PubMed ID: 7544458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.